Fundraising Fox
Diantpharma
Manchester, US · Founded 2019
Find your way into Diantpharma
Sign up to see every warm intro you have to Diantpharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Diantpharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DIANT develops proprietary Jet technology and continuous, closed manufacturing systems for producing nanoparticles and lipid nanoparticles (LNPs), and offers R&D through manufacturing services. Its systems serve customers making nanoparticle products for pharmaceuticals, nutraceuticals, food, beverage, and cosmetics.
Founders & leadership
Diantpharma was founded in 2019 by Diane Burgess and Antonio Costa.
Reported raises · per SEC filings
Form D private placements$1.4M disclosed across 1 round · 2022
▶$1.4MraisedSep 2022 · 4 investors · BiotechnologyRule 506(b)
- Diane BurgessExecutive Officer, Director
- Antonio CostaExecutive Officer, Director
- Offering amount
- $4.8M
- Amount sold
- $1.4M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2022 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Diantpharma do?
- DIANT develops proprietary Jet technology and continuous, closed manufacturing systems for producing nanoparticles and lipid nanoparticles (LNPs), and offers R&D through manufacturing services. Its systems serve customers making nanoparticle products for pharmaceuticals, nutraceuticals, food, beverage, and cosmetics.
- Who founded Diantpharma?
- Diantpharma was founded by Diane Burgess, Antonio Costa in 2019.
- How much funding has Diantpharma raised?
- Diantpharma has disclosed $1.4M raised across 1 round.
- Where is Diantpharma headquartered?
- Diantpharma is headquartered in Manchester, US.